Eli Lilly's Weight-Loss Drug Zepbound Is Cheaper Than Wegovy
Eli Lilly priced its new weight-loss drug Zepbound 20% lower than competitor Wegovy, an unusual move in the pharmaceutical world.
Source: businessinsider.com
Stay updated with breaking news from Eli Lilly Mason. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Eli Lilly priced its new weight-loss drug Zepbound 20% lower than competitor Wegovy, an unusual move in the pharmaceutical world.